BioNexus Gene Lab Corp. (BGLC)
0.25
-0.05 (-16.44%)
At close: Mar 28, 2025, 3:58 PM
0.26
1.96%
Pre-market: Mar 31, 2025, 07:20 AM EDT
BioNexus Gene Lab Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| Cash & Equivalents | 5.93M | 2.12M | 2.12M | 2.79M | 859.08K | 1.26M | 839.14K | 26.00 |
| Short-Term Investments | n/a | 1.51M | 1.55M | 2.09M | 493.04K | 601K | 2.55K | n/a |
| Long-Term Investments | 1.7M | 1.15M | 749.03K | 281.67K | 12.21K | 12.08K | n/a | n/a |
| Other Long-Term Assets | n/a | -2.72M | n/a | -2.13M | -348.67K | n/a | n/a | n/a |
| Receivables | 857.26K | 2.9M | 3.36M | 4M | 15.91K | n/a | n/a | n/a |
| Inventory | 1.14M | 977.81K | 1.52M | 1.18M | 7.58K | 15.3K | 32.09K | n/a |
| Other Current Assets | 122.43K | n/a | 147.12K | n/a | n/a | 22.81K | 125.94K | n/a |
| Total Current Assets | 8.05M | 6.02M | 7.15M | 7.99M | 882.57K | 1.3M | 999.72K | 26.00 |
| Property-Plant & Equipment | 1.65M | 1.57M | 1.68M | 1.85M | 336.45K | 341.81K | 273.16K | n/a |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 3.35M | 2.72M | 2.42M | 2.13M | 348.67K | 353.88K | 273.16K | n/a |
| Total Assets | 11.4M | 8.74M | 9.57M | 10.12M | 1.23M | 1.65M | 1.27M | 26.00 |
| Account Payables | 1.4M | 1.86M | 2.01M | 3.17M | n/a | n/a | 35.09K | 1.34K |
| Deferred Revenue | n/a | 23.12K | 107.58K | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | 34.63K | 33.14K | 79.01K | 91.5K | 64.27K | 19.13K | n/a | n/a |
| Other Current Liabilities | 194.11K | 86.8K | 32.31K | 50.13K | -12.7K | 11.15K | 1.14M | n/a |
| Total Current Liabilities | 1.63M | 2M | 2.33M | 3.37M | 51.57K | 62.89K | 1.17M | 1.34K |
| Long-Term Debt | 98.76K | 40.21K | 37.44K | 77.67K | 12.21K | 62.94K | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | 45.09K | n/a | n/a | n/a |
| Total Long-Term Liabilities | 111.02K | 71.07K | 65.86K | 79.54K | 57.3K | 67.42K | 4.57K | n/a |
| Total Liabilities | 1.74M | 2.08M | 2.39M | 3.45M | 108.87K | 130.31K | 1.18M | 1.34K |
| Total Debt | 133.4K | 56.77K | 76.95K | 123.42K | 89.44K | 82.06K | n/a | n/a |
| Common Stock | 17.19M | 10.93M | 10.78M | 10.78M | 6.48M | 6.65M | 5.21M | 1.00 |
| Retained Earnings | -1.84M | 1.16M | 1.51M | 760.79K | -333.31K | -86.84K | -113.3K | -1.44K |
| Comprehensive Income | -677.29K | -409.06K | -100.26K | 133.68K | -17.1K | -26.98K | 14.05K | 126.00 |
| Shareholders Equity | 9.66M | 6.67M | 7.18M | 6.66M | 1.12M | 1.52M | 94.63K | -1.31K |
| Total Investments | 1.7M | 1.15M | 749.03K | 281.67K | 12.21K | 12.08K | 2.55K | n/a |